A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators
NCT00162448
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Heart Diseases
Interventions
DRUG:
BMS-394136
DRUG:
Placebo
Sponsor
Bristol-Myers Squibb